Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access |
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc |
Journal website https://gr.elmerpub.com |
Original Article
Volume 000, Number 000, March 2025, pages 000-000
Incidence of Inflammatory Bowel Disease in Children
Figures
Tables
Characteristic | IBD (n = 118) (100%) | IBD (n = 118) (100%) | |||
---|---|---|---|---|---|
UC (n = 57) (48.3%) | CD (n = 48) (40.68%) | IBD-U (n = 13) (11.02%) | P | ||
aRural: less than 2000 inhabitants. bUrban: more than 2000 inhabitants. CD: Crohn’s disease; IBD: inflammatory bowel disease; IBD-U: unclassified inflammatory bowel disease; SD: standard deviation; UC: ulcerative colitis. | |||||
Age at the time of diagnosis in years | 0.066 | ||||
Mean ± SD | 11.67 ± 4.15 | 12.47 ± 3.52 | 11.38 ± 4.5 | 9.23 ± 4.59 | |
Min - Max | 2 - 18 | 4 - 17 | 2 - 18 | 3 - 17 | |
Sex, n (%) | 0.892 | ||||
Girls | 52 (44%) | 25 (44%) | 22 (46%) | 5 (38%) | |
Boys | 66 (56%) | 32 (56%) | 26 (54%) | 8 (62%) | |
Place of residence, n (%) | 0.379 | ||||
Rurala | 36 (31%) | 21 (37%) | 12 (25%) | 3 (23%) | |
Urbanb | 82 (69%) | 36 (63%) | 36 (75%) | 10 (77%) | |
First-degree relatives of IBD, n (%) | 18 (15%) | 7 (12%) | 10 (21%) | 1 (8%) | 0.174 |
Mother | 9 (8%) | 2 (4%) | 7 (15%) | 0 (0%) | |
Father | 5 (4%) | 2 (4%) | 2 (4%) | 1 (8%) | |
Siblings | 4 (3%) | 3 (5%) | 1 (2%) | 0 (0%) |
Characteristic | 2011 – 2022, n = 118 (100%) | 2011 – 2016, n = 48 (100%) | 2017 – 2022, n = 70 (100%) | P |
---|---|---|---|---|
CD: Crohn’s disease; IBD: inflammatory bowel disease; UC: ulcerative colitis. | ||||
Mean age of onset of the first symptoms in years | ||||
IBD | 10.48 ± 4.57 | 9.33 ± 4.95 | 11.27 ± 4.41 | 0.023 |
UC | 11.40 ± 4.25 | 10.26 ± 5.42 | 11.97 ± 3.47 | 0.363 |
CD | 10.06 ± 4.74 | 9.81 ± 4.64 | 10.26 ± 4.9 | 0.594 |
Mean age of diagnosis in years | ||||
IBD | 11.67 ± 4.15 | 10.75 ± 4.51 | 12.3 ± 3.79 | 0.046 |
UC | 12.47 ± 3.52 | 12.11 ± 3.94 | 12.66 ± 3.32 | 0.734 |
CD | 11.38 ± 4.5 | 10.71 ± 4.57 | 11.89 ± 4.47 | 0.296 |
Age at the time of diagnosis | ||||
IBD | 0.013 | |||
< 6 years of age | 15 (12.71%) | 11 (22.92%) | 4 (5.71%) | |
≥ 6 years of age | 103 (87.29%) | 37 (77.08%) | 66 (94.29%) | |
UC | 0.033 | |||
< 6 years of age | 3 (2.54%) | 3 (6.25%) | 0 (0.00%) | |
≥ 6 years of age | 54 (45.76%) | 16 (33.33%) | 38 (54.29%) | |
CD | 0.715 | |||
< 6 years of age | 8 (6.78%) | 4 (8.33%) | 4 (5.71%) | |
≥ 6 years of age | 40 (33.90%) | 17 (35.42%) | 23 (32.86%) | |
Sex | ||||
IBD | 0.896 | |||
Girls | 52 (44.07%) | 21 (43.75%) | 31 (44.29%) | |
Boys | 66 (55.93%) | 27 (56.25%) | 39 (55.71%) | |
UC | 0.925 | |||
Girls | 25 (21.19%) | 8 (16.67%) | 17 (24.29%) | |
Boys | 32 (27.12%) | 11 (22.92%) | 21 (30.00%) | |
CD | 0.942 | |||
Girls | 22 (18.64%) | 10 (20.83%) | 12 (17.14%) | |
Boys | 26 (22.03%) | 11 (22.92%) | 15 (21.43%) | |
Severity of course/number of patients on biological therapy | 0.024 | |||
IBD | 36 (30.5%) | 17 (35.42%) | 19 (27.14%) | |
UC | 15 (12.71%) | 4 (8.33%) | 11 (15.71%) | |
CD | 17 (14.41%) | 9 (18.75%) | 8 (11.43%) | |
Severity of course/number of patients without biological therapy | 0.851 | |||
IBD | 82 (69.49%) | 31 (64.58%) | 51 (72.86%) | |
UC | 41 (34.75%) | 15 (31.25%) | 27 (38.57%) | |
CD | 31 (26.27%) | 12 (25%) | 19 (27.14%) | |
Place of residence | ||||
IBD | 0.641 | |||
Urban | 82 (69.49%) | 35 (72.92%) | 47 (67.14%) | |
Rural | 36 (30.51%) | 13 (27.08%) | 23 (32.86%) | |
UC | 0.771 | |||
Urban | 36 (30.51%) | 11 (22.92%) | 25 (35.71%) | |
Rural | 21 (17.80%) | 8 (16.67%) | 13 (18.57%) | |
CD | 0.867 | |||
Urban | 36 (30.51%) | 16 (33.33%) | 20 (28.57%) | |
Rural | 12 (10.17%) | 5 (10.42%) | 7 (10.00%) |
Seasons | 2011 - 2022, n = 118 (100%) | 2011 - 2016, n = 48 (100%) | 2017 - 2022, n = 70 (100%) | P |
---|---|---|---|---|
CD: Crohn’s disease; IBD: inflammatory bowel disease; UC: ulcerative colitis. | ||||
Spring, n (%) | 0.276 | |||
IBD | 34 (28.8%) | 16 (33.33%) | 18 (24.71%) | |
UC | 18 (15.25%) | 6 (12.5%) | 12 (17.14%) | |
CD | 10 (8.47%) | 6 (12.5%) | 4 (5.71%) | |
Summer, n (%) | 0.875 | |||
IBD | 31 (26.27%) | 14 (29.17%) | 17 (24.29%) | |
UC | 15 (12.71%) | 6 (12.5%) | 9 (12.86%) | |
CD | 13 (11.01%) | 7 (14.58%) | 6 (8.57%) | |
Autumn, n (%) | 0.479 | |||
IBD | 33 (27.97%) | 10 (20.83%) | 23 (32.86%) | |
UC | 16 (13.56%) | 5 (10.42%) | 11 (15.71%) | |
CD | 16 (13.56%) | 4 (8.33%) | 12 (17.14%) | |
Winter, n (%) | 0.580 | |||
IBD | 20 (16.95%) | 8 (16.67%) | 12 (17.14%) | |
UC | 8 (6.78%) | 2 (41.17%) | 6 (8.57%) | |
CD | 9 (7.63%) | 4 (8.33%) | 5 (7.14%) |